Synergistic Effect of YK-4-279 and Paclitaxel on A549 Cell Line
Lung cancer, among all cancer types around the world, is listed as the major cause of death with high mortality rate. ERG transcription factor has an important role in the Epithelial Mesenchymal Transition (EMT), which is one of the most important mechanisms in lung cancer progression. It is known t...
Main Authors: | Sara Alkhatib, Emine Kandemiş, Gamze Gizir, Gülay Bulut |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-12-01
|
Series: | Proceedings |
Subjects: | |
Online Access: | https://www.mdpi.com/2504-3900/2/25/1588 |
Similar Items
-
Effect of Etoposide Treatment on ERG Transfected H358 Cell Line
by: Emine Kandemiş, et al.
Published: (2018-12-01) -
The ETS Inhibitor YK-4-279 Suppresses Thyroid Cancer Progression Independent of TERT Promoter Mutations
by: Junyu Xue, et al.
Published: (2021-06-01) -
Improved Synthesis and Determination of the Biologically Active Diastereomer of YK11
by: Yuichiro Kanno, et al.
Published: (2020-04-01) -
p53 Loss Mediates Hypersensitivity to ETS Transcription Factor Inhibition Based on PARylation-Mediated Cell Death Induction
by: Carina Dinhof, et al.
Published: (2020-10-01) -
In vivo synergistic anti-tumor effect of paclitaxel nanoparticles combined with radiotherapy on human cervical carcinoma
by: YanXin Yu, et al.
Published: (2017-01-01)